The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Timothy Lash named leader of cancer prevention program at Winship Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

TIMOTHY LASH was named leader of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory University.

Andrew Miller will continue to serve as co-leader of the program. Lash succeeds Roberd “Robin” Bostick, who served as leader of the program since 2008.

Lash is a professor of epidemiology in the Emory University Rollins School of Public Health; he joined the university in 2013. His research focuses on molecular biomarkers that predict cancer recurrence. He also is interested in age-related disparities in the quality of cancer care.

Earlier this year, Lash was among a select group that received the Emory 1% Award recognizing faculty whose competitive research grant application is ranked in the first percentile. Lash also serves as the editor-in-chief of Epidemiology. He previously held faculty appointments at Wake Forest University School of Medicine, the University of Aarhus in Denmark, and Boston University’s Schools of Public Health and Medicine.

Table of Contents

YOU MAY BE INTERESTED IN

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa
With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

Pfizer External Research & Grants’ “Improving Breast Cancer Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa,” powered by EveryGrant, has announced grants totaling more than $900,000 for addressing inequities and improving the quality of breast cancer care in Sub-Saharan Africa.
By Claire Marie Porter
ClinicalTrials & Tribulations

The other side of the patient portal: Reflections from a cancer center leader

It started innocuously enough. I looked in the mirror and noticed a pigmented area on my scalp just into the hairline. Like many patients, thoughts started running through my head: “Maybe it’s nothing.” Looking at my Outlook calendar, it was packed morning-to-night with meetings, patients, and travel, so I decided I would get that spot checked out the minute I had “time.” 
By Ruben A. Mesa
Cancer Policy

A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”

In the morning of May 28, presumably before turning off the lights and closing the office door, someone at the now defunct NCI Office of Communications and Public Liaision decided to post a farewell message to the cancer community.  The message, posted on multiple social media accounts, read: We’re taking a pause here - but...

By Jacquelyn Cobb
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account